Dartmouth-Hitchcock Helps Open New COVID-19 Clinical Trials in Six Days

Dartmouth-Hitchcock Health just helped open two Phase III COVID-19–related therapeutic studies in six business days. The Gilead-sponsored studies, one of patients with moderate COVID-19 and the other with patients suffering more serious symptoms, are evaluating the safety and antiviral activity of Remdesivir (GS-5734™) against the condition.

Rutgers School of Health Professions Faculty Joins ACRP Partners in Workforce Advancement

The Association of Clinical Research Professionals (ACRP) welcomes Rutgers School of Health Professions Clinical Research Management Program Director Doreen W. Lechner, PhD as a Workforce Champion member of the Partners in Workforce Advancement. Partners in Workforce Advancement is a multi-stakeholder collaborative initiative to grow the clinical research workforce and to set and support standards […]

FDA Issues Guidance Authorizing Use of Some Emergency Ventilators

The U.S. Food and Drug Administration (FDA) has issued a guidance authorizing the emergency use of ventilators, anesthesia gas machines modified for use as ventilators, and positive pressure breathing devices modified for use as ventilators, ventilator tubing connectors, and ventilator accessories that FDA determines meet the criteria for certain safety, performance, and labeling criteria in […]

Raymond Nomizu, CEO of Clinical Research IO

New Patient Enrollment Efforts Stalled by Coronavirus Obstacles

From movie theaters to restaurants to shopping malls, coronavirus-inspired closures are already impacting the national economy in significantly negative ways. The same phenomenon appears to be damaging clinical trials, says a new survey from Clinical Research IO. Even at this relatively early stage in the health crisis, 24% of principal investigators (PIs) surveyed reported that […]